Key statistics
On Monday, Metagenomi Inc (MGX:NSQ) closed at 1.53, 24.39% above the 52 week low of 1.23 set on Apr 04, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.46 |
|---|---|
| High | 1.62 |
| Low | 1.46 |
| Bid | 1.49 |
| Offer | 1.51 |
| Previous close | 1.52 |
| Average volume | 179.09k |
|---|---|
| Shares outstanding | 37.53m |
| Free float | 26.53m |
| P/E (TTM) | -- |
| Market cap | 57.43m USD |
| EPS (TTM) | -2.39 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
- Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook
- Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference
- Metagenomi to Present at Jefferies Global Healthcare Conference in London
- Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership Updates
- Metagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting Advancement into Clinical Development
- Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results
- Metagenomi Appoints Laurence Reid, PhD to its Board of Directors
- Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025
- Metagenomi Reports Business Updates and First Quarter 2025 Financial Results
More ▼
